Science Advisory Committee on Health Products Containing Cannabis: Agenda for November 30 and December 2 web conference

Monday, November 30, 2020, 2:30 - 5:00 pm Eastern standard time (EST) and Wednesday, December 2, 2020, 2:45 - 5:00 pm (EST)

Purpose: This web conference will focus on the evidence regarding the safety and efficacy of cannabis, as well as examples of products currently used. The meeting will take place over 2 separate sessions, and close by seeking the Committee’s initial views regarding the appropriate scope of products, populations of concern, and other topics.

  Time
(EST)
Agenda
Day 1 – November 30, 2020
1 2:30 – 2:35pm Welcome and introductory remarks
Presenter: Ed Morgan, Director General of Policy Planning and International Affairs Directorate (PPIAD) and Committee Co-Chairs
2 2:35 – 3:00 pm Health Canada overview of evidence for cannabis use in humans
Presenter: PPIAD with support from Controlled Substances and Cannabis Branch (CSCB), Therapeutic Products Directorate (TPD) and Natural and Non-prescription Health Products Directorate (NNHPD)
3 3:00 - 3:25 pm Canadian Institutes of Health Research (CIHR) Integrated Cannabis Research Strategy
Presenter: Dr. Sam Weiss, Scientific Director of the CIHR Institute of Neurosciences, Mental Health and Addiction
4 3:25 - 3:50 pm National Academies of Sciences, Engineering, and Medicine (NASEM) report on the Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research (2017)
Presenter: Dr. Ziva Cooper, Director, University of California, Los Angeles (UCLA) Cannabis Research Initiative; Associate Professor, Psychiatry and Biobehavioral Science, UCLA Semel Institute for Neuroscience and Human Behaviour
5 3:50 – 4:05 pm Short break
6 4:05 - 4:30 pm Adverse Reactions associated with Cannabis Products Reported to Health Canada
Presenter: Stephanie Jack, Manager, Office of Cannabis Science and Surveillance, CSCB
7 4:30 pm - 4:55 pm World Health Organization’s Expert Committee on Drug Dependence (ECDD)
Presenter : Dr. Bruna Brands, Senior Science Advisor, Office of Drug Science and Surveillance, CSCB, Health Canada; Professor, Department of Pharmacology and Toxicology, University of Toronto; Member of the ECDD, World Health Organization
8 4:55 pm – 5:00 pm Closing remarks
Presenter: Ed Morgan and Committee Co-Chairs
  Time
(EST)
Agenda
Day 2 – December 2, 2020
1 2:45 – 2:50 pm Welcome and introductory remarks
Presenter: Ed Morgan and Committee Co-Chairs
2 2:50 – 3:10 pm Discussion of product examples for animal use
Presenter: Veterinary Drugs Directorate
3 3:10 – 3:40 pm Discussion of product examples for human use (non-prescription)
Presenters: PPIAD, CSCB and NNHPD
4 3:40 – 3:50 pm Short break
5 3:50 – 4:35 pm
Working discussion
Discussion on current state of evidence for use in humans
Discussion facilitated by Committee Co-Chairs
6 4:35 – 4:55 pm Discussion of next steps
Lead: PPIAD and Committee Co-Chairs
7 4:55 – 5:00 pm Closing remarks
Presenter: Ed Morgan and Committee Co-Chairs
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: